Oldest-old type 1 diabetes patient receiving insulin pump treatment with positive myeloperoxidase-antineutrophil cytoplasmic antibody complication: A case report

Geriatr Gerontol Int. 2019 Sep;19(9):957-958. doi: 10.1111/ggi.13683.

Authors

Affiliations

¹ Department of Diabetes, Metabolism, and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
² Department of Geriatric Medicine, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
³ Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
⁴ Department of Nephrology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.

PMID: 31490005
DOI: 10.1111/ggi.13683

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aftercare / methods
Aged, 80 and over
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / blood
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / complications
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / physiopathology
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / therapy
Antibodies, Antineutrophil Cytoplasmic / blood*
Creatinine / blood
Dementia / complications
Diabetes Mellitus, Type 1* / blood
Diabetes Mellitus, Type 1* / complications
Diabetes Mellitus, Type 1* / drug therapy
Hematuria* / diagnosis
Hematuria* / etiology
Humans
Hypoglycemic Agents / administration & dosage
Infusion Pumps, Implantable
Insulin / administration & dosage*
Male

Substances

Antibodies, Antineutrophil Cytoplasmic
Hypoglycemic Agents
Insulin
Creatinine